By Sheri Kasprzak
New York, March 29 - MorphoSys AG said it concluded a €17,103,041 private placement with a group of institutional investors.
The investors bought 384,338 shares at €44.50 each.
WestLB AG was the bookrunner for the offering, with DZ Bank AG as co-agent.
Following the placement, the number of MorphoSys' issued shares will increase to 6,639,618 from 6,234,423.
Proceeds will be used for the expansion of the company's antibody business.
Based in Munich, MorphoSys develops synthetic antibodies used to accelerate drug discovery and target characterization.
| Issuer: | MorphoSys AG
|
| Issue: | Stock
|
| Amount: | €17,103,041
|
| Shares: | 384,338
|
| Price: | €44.50
|
| Warrants: | No
|
| Placement agents: | WestLB AG (lead), DZ Bank AG
|
| Settlement date: | March 29
|
| Stock symbol: | Frankfurt: MOR
|
| Stock price: | €44.90 at close March 28
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
